Publication

The following are some of the academic articles which have used MDV data.

Academic Articles

Total number of publications

789

Publication Icon

Search for Articles

The term "full-match search" refers to searching for items that contain all the words entered, while "partial-match search" refers to searching for items that contain even one of the words entered.

~

Search results: 24

Download Publication List

2025

TitleRisk factors for lower adherence to epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer: A nationwide retrospective cohort study in Japan
AuthorsYasutaka Ihara, Shoichiro Yamamoto, Megumi Mizutani, Shinji Akiyama, Naoto Okada, Yuki Shimomura
PublishedOncology (2025)
Therapeutic AreaNon-small cell lung cancer
TitleEffects of Low-Dose Ipilimumab Formulation on the Prescription Volume and Drug Costs in Japan
AuthorsToshikazu Ichie, Daisuke Suzuki, Shuji Yamashita, Takeshi Miura, Kunio Naruse, Hideki Hayashi
PublishedBPB Reports
Therapeutic AreaNon-small cell lung cancer
TitleAssociation Between Immunotherapy and Overall Survival in Malnourished Patients with Advanced Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan
AuthorsMaya Shimasaki, Yasutaka Ihara, Shoichiro Yamamoto, Haruki Takata &Shinji Akiyama
PublishedNutrition and Cancer
Therapeutic AreaNon-small cell lung cancer
TitleTreatment Patterns and Outcomes in Patients with Resectable Early-stage NSCLC in Japan.
AuthorsKentaro Ito, Natsumi Okuyama, Russell Miller, Fanryuan Wang and Yuichiro Ito
Published新薬と臨牀
Therapeutic AreaNon-small cell lung cancer
TitleAssociation between pleurodesis before immunotherapy and pneumonitis in non-small cell lung cancer
AuthorsMegumi Mizutani, Yasutaka Ihara, Kenj Sawa, Akira Sugimoto,Hiroaki Nagamine, Yoshiya Matsumoto, Yoko Tani, Takako Oka, Hiroyasu Kaneda, Tsubasa Bito, Tomoya Kawaguchi, Ayumi Shintani
PublishedRespiratory Investigation
Therapeutic AreaNon-small cell lung cancer
TitleEffect of Concomitant Metformin Use on Hematologic Adverse Events in Non-Small-Cell Lung Cancer Patients Undergoing Pemetrexed-Based Chemotherapy: A Study Using a Japanese Claims Database
AuthorsMasahiro Hayafune, Shungo Imai, Hayato Kizaki, Masami Tsuchiya, Satoko Hori
PublishedYakugaku Zasshi
Therapeutic AreaNon-small cell lung cancer

2024

TitleEvaluating the impact of atezolizumab on febrile neutropenia occurrence in patients with NSCLC undergoing chemotherapy in Japan: a real-world post-marketing database study
AuthorsSayuri Nakane, Akinori Yuri, Yuki Miyano, Kana Yamada, Erika Nakatsuji, Nobuki Takei, Yasuhiro Igarashi & Ryousuke Harada
PublishedInternational Journal of Clinical Oncology
Therapeutic AreaNon-small cell lung cancer
Title診療情報データベースを用いた非小細胞肺がん患者に対するペメトレキセド含有化学療法における血液毒性へのメトホルミン併用の影響評価
Authors早船 真弘, 今井 俊吾, 木﨑 速人, 土屋 雅美, 堀 里子
PublishedYAKUGAKU ZASSHI
Therapeutic AreaNon-small cell lung cancer
TitleImmunotherapy Following Anaplastic Lymphoma Kinase Inhibitor Therapy for Patients with Anaplastic Lymphoma Kinase‑Positive Non‑small Cell Lung Cancer in Japan
AuthorsYuki Shimomura, Megumi Mizutani, Hisako Yoshida, Yasutaka Ihara & Ayumi Shintani
PublishedTargeted Oncology
Therapeutic AreaNon-small cell lung cancer
TitleEffects of dementia on functional decline in patients with non-small cell lung cancer at discharge from acute care hospitals: A retrospective cohort study
AuthorsKayo Hirooka, Yasuyuki Okumura, Jun Hamano, Junko Nozato, Sakiko Fukui, Asao Ogawa
PublishedJournal of Geriatric Oncology
Therapeutic AreaNon-small cell lung cancer
TitleImmunotherapy and Overall Survival Among Patients With Advanced Non–Small Cell Lung Cancer and Obesity
AuthorsYasutaka Ihara, Kenji Sawa, Takumi Imai, Tsubasa Bito, Yuki Shimomura, Ryota Kawai, Ayumi Shintani
PublishedJAMA Network Open
Therapeutic AreaNon-small cell lung cancer
TitleA DPC Database Study on the Safety of Atezolizumab/Bevacizumab/Carboplatin/Paclitaxel in Non-small Cell Lung Cancer in Japanese Patients
AuthorsAkito Hata, Shunichiro Iwasawa, Yusuke Sasaki, Kosei Tajima & Yasutaka Chiba
PublishedAdvances in Therapy
Therapeutic AreaNon-small cell lung cancer
TitleImmune Checkpoint Inhibitor Is Associated with Improved Survival in Advanced Non-small Cell Lung Cancer Occurring in Patients with Autoimmune Disease
AuthorsYasutaka Ihara, Kenji Sawa, Takumi Imai, Yuta Nonomiya, Yuki Shimomura, Asahi Ishihara, Ayumi Shintani
PublishedBiological and Pharmaceutical Bulletin
Therapeutic AreaNon-small cell lung cancer

2023

TitleReal-world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK-positive NSCLC
AuthorsYasushi Goto, Takehito Shukuya, Ai Murata, Hironori Kikkawa, Birol Emir, Robin Wiltshire, Satoru Miura
PublishedCancer Science
Therapeutic AreaNon-small cell lung cancer
TitleReal-world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK-positive non-small-cell lung cancer
AuthorsYasushi Goto, Takehito Shukuya, Ai Murata, Hironori Kikkawa, Birol Emir, Robin Wiltshire, Satoru Miura
PublishedCancer Science
Therapeutic AreaNon-small cell lung cancer
TitleReal-World Data About Treatment Outcomes for Patients with EGFR-Mutated NSCLC Resistance to Osimertinib and Platinum-Based Chemotherapy
AuthorsHidetoshi Hayashi, Makoto Nishio, Michiko Takahashi, Hiroaki Tsuchiya & Mami Kasahara-Kiritani
PublishedAdvances in Therapy
Therapeutic AreaNon-small cell lung cancer
TitleEffectiveness of crizotinib in patients with ROS1-positive non-small-cell lung cancer: real-world evidence in Japan
AuthorsNaoyuki Nogami, Atsushi Nakamura, Naoko Shiraiwa, Hironori Kikkawa, Birol Emir, Robin Wiltshire & Masahiro Morise
PublishedFuture Oncology
Therapeutic AreaNon-small cell lung cancer
TitleLack of Association Between Immunotherapy and Improvement of Survival for Non-small Cell Lung Cancer Patients With Hemodialysis: A Nationwide Retrospective Cohort Study
AuthorsKenji Sawa, Yasutaka Ihara, Takumi Imai, Akira Sugimoto, Hiroaki Nagamine, Koichi Ogawa, Kenji Nakahama, Yoshiya Matsumoto, Yoko Tani, Hiroyasu Kaneda, Shigeki Mitsuoka, Tomoya Kawaguchi, Ayumi Shintani
PublishedClinical Lung Cancer
Therapeutic AreaNon-small cell lung cancer
TitleMO5-5 Comparison of first-line therapy regimens for non-small cell lung cancer with different Japanese real world data sources
AuthorsMariko Nio, Michiyasu Inatani, Hiroko Igarashi, Takatsugu Narikiyo, Ryouichi Chatani, Yasuo Sugitani
PublishedAnnals of Oncology
Therapeutic AreaNon-small cell lung cancer
TitleTreatment sequencing after failure to alectinib in patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer
AuthorsYuki Shimomura, Kenji Sawa, Takumi Imai, Yasutaka Ihara, Hisako Yoshida, Ayumi Shintani
PublishedCancer Science
Therapeutic AreaNon-small cell lung cancer

2022

TitleBudget impact analysis of next-generation sequencing versus sequential single-gene testing in Japanese patients with advanced non-small-cell lung cancer
AuthorsHiroyuki Matsuda, Toru Ogawa, Yasunari Sadatsuki, Toshiaki Tsujino, Shingo Wada, Seok-Won Kim, Yutaka Hatanaka
PublishedRespiratory Investigation
Therapeutic AreaNon-small cell lung cancer
TitleP28-6 Real-world evidence of crizotinib for ROS1-tested patients with non-small cell lung cancer in Japan
AuthorsMasahiro Morise
PublishedAnnals of Oncology
Therapeutic AreaNon-small cell lung cancer

2020

TitleTreatment Sequencing in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in Japan: A Real-World Observational Study
AuthorsYasushi Goto, Nobuyuki Yamamoto, Elizabeth T. Masters, Hironori Kikkawa, Jack Mardekian, Robin Wiltshire, Kanae Togo & Yuichiro Ohe
PublishedAdvances in Therapy
Therapeutic AreaNon-small cell lung cancer

2017

TitleSystemic Treatment Patterns With Advanced or Recurrent Non–small Cell Lung Cancer in Japan: A Retrospective Hospital Administrative Database Study
AuthorsFeng Wang, Sari Mishina, Shinji Takai, T. Kim Le, Kenya Ochi, Kotaro Funato, Shozo Matsuoka, Yuichiro Ohe
PublishedClinical Therapeutics June 2017
Therapeutic AreaNon-small cell lung cancer

About Japanese Healthcare System

What you need to know about the healthcare system in Japan before using the data.

SERVICE

In addition to various web tools that allow you to easily conduct surveys via a browser using our medical database, we offer data provision services categorized into four types to meet your needs and challenges: "Analysis reports" "Datasets," "All Therapeutic Areas Data Provision Service," and "Specific Therapeutic Areas Data Provision Service.

page top